ImmPACT Bio is a startup based in the United States, most recent round Acquired, 1 tracked investor.
ImmPACT Bio is a company headquartered in the United States. ImmPACT Bio has been acquired. Brouky records 1 investor associated with the company.
ImmPACT Bio develops next-generation CAR T-cell therapies focusing on innovative immunotherapy treatments for cancer.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.